Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid in osteoporosis with type 2 diabetes mellitus
ChiCTR1800017906Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of zoledronic acid in osteoporosis (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Bone turnover markers. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR1800017906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017906.